The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma

OBJECTIVE: The objective is to explore the effectiveness and safety of CAR T-cell therapy in advanced relapsed/refractory central nervous system B-cell lymphoma and compare the impact of autologous stem cell transplantation (ASCT) plus CAR T-cell therapy versus sequential CART therapy on the surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Fei, Zheng, Peihao, Liu, Rui, Feng, Shaomei, Guo, Yuelu, Shi, Hui, Liu, Haidi, Deng, Biping, Xu, Teng, Ke, Xiaoyan, Hu, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726247/
https://www.ncbi.nlm.nih.gov/pubmed/36483984
http://dx.doi.org/10.1155/2022/2900310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726247/
https://www.ncbi.nlm.nih.gov/pubmed/36483984
http://dx.doi.org/10.1155/2022/2900310

Ejemplares similares